Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Derivatives -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (156)	5/6/1999 4:52:00 PM
From: LLCF	Read Replies (1) \| Respond to of 555

<Cephalon earnings? There seems to be a personal touch to this calendar.> :)......... Acutally, any announcement that could create a non-normal move in the stock is fair game. Bio-earnings(losses?) normally wouldn't qualify because no one cares, but with a new drug ramp-up being followed I figure it's important (plus I own the stock!). If you know of any that are important I'll fire 'em in gladly. I'm a little peaved I didn't get more Oct. 5 calls in NBIX. (I own about 1/2 of the open interest) On the other hand, we could use some excitement in the sector and a bounce in these silly cheap stocks. BTRN perking up as well, traded $3 today. DAK DAK